Research Article: A Retrospective Study of Anlotinib Combined with Anti-PD- Inhibitors in the nd or Later-Line Treatment of Advanced Solid Tumors
Introduction:
In recent years, the overall incidence and mortality of cancer in China are increasing year by year, and cancer has become a major public health problem that seriously threatens the health of Chinese residents. Drug therapy is a very important treatment, including chemotherapy, immunotherapy, targeted therapy, endocrine therapy, and so on. Among them, anti-angiogenic drugs and immune checkpoint inhibitors (ICIs) play a more and more important role in the treatment of malignant tumors in recent years. ,
Read more